Skip to content

Sign in Start free

Create your free account

Loading your page…

We care for the people who care.

No ads. No selling of your data. No third-party trackers.

Apps

Prognia
Ward
Suture
Osler

Library

Guidelines
Medicines
Articles
Calculators
Explore decks
Institutions
Pharmaceutical companies
Blog

Prognia

About
Pricing
Contact

Support us

Founders Wall

© 2026 Prognia · Amsterdam, the NetherlandsPrivacy TermsExchangeRate-API

Loading…

Medicines
Netherlands
Volanesorsen

CBG-MEB 2019

Volanesorsen

Waylivra 285 mg oplossing voor injectie in voorgevulde spuit

Oplossing voor injectieNetherlandsAuthorisedAuthorised 3 May 2019

Product informationAsk Osler about it

On this page

In other countries
Documents
Sources and licences

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

WaylivraEuropean UnionAuthorised

WaylivraBrazil · PTC Farmaceutica do Brasil Ltda.Same brand
Waylivra 285 MG Solucion Inyectable en Jeringa PrecargadaSpain · 300 mg · solución inyectable en jeringa precargada · Akcea Therapeutics Ireland LimitedSame brand
WaylivraEuropean Union · Akcea Therapeutics Ireland LimitedSame brand
WaylivraCroatiaSame brand
WaylivraItaly · Soluzione iniettabile · Akcea Therapeutics Ireland LimitedSame brand

Documents

The official texts, at the regulator.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Summary of product characteristicsCBG-MEB

Register entryCBG-MEB

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

College ter Beoordeling van Geneesmiddelen

College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.

Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim · Added 8 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Volanesorsen
Dosage form: Oplossing voor injectie
Register: Netherlands (CBG-MEB)
Status: Authorised
Status in the register: Ingeschreven
Authorised: 3 May 2019
Registration: EU/1/19/1360
Marketing authorisation holder: Akcea Therapeutics Ireland Ltd
ATC code: C10AX18
Group: Cardiovascular system
Procedure: EU centralised
Supply: Uitsluitend recept
EMA product number: EMEA/H/C/004538
EU number: EU/1/19/1360